Global Human Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 08-Apr-2019
No. of pages: 127
Inquire Before Buying

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins.

China Human Vaccine is widely used for adults and children. The most proportion of China Human Vaccine is children, and the sales market share in 2017 is 64.6%.

The classification of China Human Vaccine includes Varicella, Influenza, Polio, Hepatitis A, Rabies, BCG, Hepatitis B, Pertussis, Diphtheria, Tetanus, Pneumococcal, Rota vaccine and other kinds of vaccines, and the proportion of Rabies in 2017 is about 20.4%.

The global Human Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Human Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Human Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Human Vaccine in these regions.

This research report categorizes the global Human Vaccine market by top players/brands, region, type and end user. This report also studies the global Human Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- CNBG

- Changsheng Life

- Zhifei

- ChengDa Bio

- Kangtai

- SINOVAC BIOTECH

- Hissen

- Walvax Biotechnology

- GSK

- SANOFI

- Rong An

- NuoCheng Bio

- Hualan Bio

- Tiantan biological

- Changchun Baike

- Adimmune

- Zhongyianke Biotech

Market size by Product

- Varicella

- Influenza

- Polio

- Hepatitis A

- Rabies

- BCG

- Hepatitis B

- Pertussis, Diphtheria, Tetanus

- Pneumococcal

- Rota vaccine

Market size by End User

- Adults

- Children

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Human Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Human Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Human Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Human Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Human Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (M Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Human Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Human Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Human Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Human Vaccine Market Size Growth Rate by Product
1.4.2 Varicella
1.4.3 Influenza
1.4.4 Polio
1.4.5 Hepatitis A
1.4.6 Rabies
1.4.7 BCG
1.4.8 Hepatitis B
1.4.9 Pertussis, Diphtheria, Tetanus
1.4.10 Pneumococcal
1.4.11 Rota vaccine
1.5 Market by End User
1.5.1 Global Human Vaccine Market Size Growth Rate by End User
1.5.2 Adults
1.5.3 Children
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Human Vaccine Market Size
2.1.1 Global Human Vaccine Revenue 2014-2025
2.1.2 Global Human Vaccine Sales 2014-2025
2.2 Human Vaccine Growth Rate by Regions
2.2.1 Global Human Vaccine Sales by Regions
2.2.2 Global Human Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Human Vaccine Sales by Manufacturers
3.1.1 Human Vaccine Sales by Manufacturers
3.1.2 Human Vaccine Sales Market Share by Manufacturers
3.1.3 Global Human Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Human Vaccine Revenue by Manufacturers
3.2.1 Human Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Human Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Human Vaccine Price by Manufacturers
3.4 Human Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Human Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Human Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Human Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Human Vaccine Sales by Product
4.2 Global Human Vaccine Revenue by Product
4.3 Human Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Human Vaccine Breakdown Data by End User
6 North America
6.1 North America Human Vaccine by Countries
6.1.1 North America Human Vaccine Sales by Countries
6.1.2 North America Human Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Human Vaccine by Product
6.3 North America Human Vaccine by End User
7 Europe
7.1 Europe Human Vaccine by Countries
7.1.1 Europe Human Vaccine Sales by Countries
7.1.2 Europe Human Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Human Vaccine by Product
7.3 Europe Human Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Human Vaccine by Countries
8.1.1 Asia Pacific Human Vaccine Sales by Countries
8.1.2 Asia Pacific Human Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Human Vaccine by Product
8.3 Asia Pacific Human Vaccine by End User
9 Central & South America
9.1 Central & South America Human Vaccine by Countries
9.1.1 Central & South America Human Vaccine Sales by Countries
9.1.2 Central & South America Human Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Human Vaccine by Product
9.3 Central & South America Human Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Human Vaccine by Countries
10.1.1 Middle East and Africa Human Vaccine Sales by Countries
10.1.2 Middle East and Africa Human Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Human Vaccine by Product
10.3 Middle East and Africa Human Vaccine by End User
11 Company Profiles
11.1 CNBG
11.1.1 CNBG Company Details
11.1.2 Company Business Overview
11.1.3 CNBG Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 CNBG Human Vaccine Products Offered
11.1.5 CNBG Recent Development
11.2 Changsheng Life
11.2.1 Changsheng Life Company Details
11.2.2 Company Business Overview
11.2.3 Changsheng Life Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Changsheng Life Human Vaccine Products Offered
11.2.5 Changsheng Life Recent Development
11.3 Zhifei
11.3.1 Zhifei Company Details
11.3.2 Company Business Overview
11.3.3 Zhifei Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Zhifei Human Vaccine Products Offered
11.3.5 Zhifei Recent Development
11.4 ChengDa Bio
11.4.1 ChengDa Bio Company Details
11.4.2 Company Business Overview
11.4.3 ChengDa Bio Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 ChengDa Bio Human Vaccine Products Offered
11.4.5 ChengDa Bio Recent Development
11.5 Kangtai
11.5.1 Kangtai Company Details
11.5.2 Company Business Overview
11.5.3 Kangtai Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Kangtai Human Vaccine Products Offered
11.5.5 Kangtai Recent Development
11.6 SINOVAC BIOTECH
11.6.1 SINOVAC BIOTECH Company Details
11.6.2 Company Business Overview
11.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 SINOVAC BIOTECH Human Vaccine Products Offered
11.6.5 SINOVAC BIOTECH Recent Development
11.7 Hissen
11.7.1 Hissen Company Details
11.7.2 Company Business Overview
11.7.3 Hissen Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Hissen Human Vaccine Products Offered
11.7.5 Hissen Recent Development
11.8 Walvax Biotechnology
11.8.1 Walvax Biotechnology Company Details
11.8.2 Company Business Overview
11.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Walvax Biotechnology Human Vaccine Products Offered
11.8.5 Walvax Biotechnology Recent Development
11.9 GSK
11.9.1 GSK Company Details
11.9.2 Company Business Overview
11.9.3 GSK Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 GSK Human Vaccine Products Offered
11.9.5 GSK Recent Development
11.10 SANOFI
11.10.1 SANOFI Company Details
11.10.2 Company Business Overview
11.10.3 SANOFI Human Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 SANOFI Human Vaccine Products Offered
11.10.5 SANOFI Recent Development
11.11 Rong An
11.12 NuoCheng Bio
11.13 Hualan Bio
11.14 Tiantan biological
11.15 Changchun Baike
11.16 Adimmune
11.17 Zhongyianke Biotech
12 Future Forecast
12.1 Human Vaccine Market Forecast by Regions
12.1.1 Global Human Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Human Vaccine Revenue Forecast by Regions 2019-2025
12.2 Human Vaccine Market Forecast by Product
12.2.1 Global Human Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Human Vaccine Revenue Forecast by Product 2019-2025
12.3 Human Vaccine Market Forecast by End User
12.4 North America Human Vaccine Forecast
12.5 Europe Human Vaccine Forecast
12.6 Asia Pacific Human Vaccine Forecast
12.7 Central & South America Human Vaccine Forecast
12.8 Middle East and Africa Human Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Human Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Human Vaccine Product Picture
Table Human Vaccine Market Segments
Table Key Manufacturers Human Vaccine Covered
Table Global Human Vaccine Market Size Growth Rate by Product 2019-2025 (M Doses) & (Million US$)
Figure Global Human Vaccine Sales Market Share by Product 2014-2025
Figure Varicella Product Picture
Table Major Manufacturers of Varicella
Figure Influenza Product Picture
Table Major Manufacturers of Influenza
Figure Polio Product Picture
Table Major Manufacturers of Polio
Figure Hepatitis A Product Picture
Table Major Manufacturers of Hepatitis A
Figure Rabies Product Picture
Table Major Manufacturers of Rabies
Figure BCG Product Picture
Table Major Manufacturers of BCG
Figure Hepatitis B Product Picture
Table Major Manufacturers of Hepatitis B
Figure Pertussis, Diphtheria, Tetanus Product Picture
Table Major Manufacturers of Pertussis, Diphtheria, Tetanus
Figure Pneumococcal Product Picture
Table Major Manufacturers of Pneumococcal
Figure Rota vaccine Product Picture
Table Major Manufacturers of Rota vaccine
Table Global Human Vaccine Market Size Growth Rate by End User 2019-2025 (M Doses)
Figure Adults
Figure Children
Figure Human Vaccine Report Years Considered
Figure Global Human Vaccine Market Size 2014-2025 (Million US$)
Figure Global Human Vaccine Sales 2014-2025 (M Doses)
Table Global Human Vaccine Market Size by Regions 2014-2019 (M Doses) & (Million US$)
Table Global Human Vaccine Sales by Regions 2014-2019 (M Doses)
Table Global Human Vaccine Sales Market Share by Regions 2014-2019
Figure Global Human Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Human Vaccine Sales Market Share by Regions
Table Global Human Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Human Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Human Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Human Vaccine Revenue Market Share by Regions
Table Global Human Vaccine Sales by Manufacturers (2014-2019) (M Doses)
Table Global Human Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Human Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Human Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Human Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Human Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Human Vaccine Price (2014-2019) (USD/Dose)
Table Human Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Human Vaccine Product Type
Table Date of International Manufacturers Enter into Human Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Human Vaccine Sales by Product (2014-2019) (M Doses)
Table Global Human Vaccine Sales Share by Product (2014-2019)
Figure Global Human Vaccine Sales Market Share by Product (2014-2019)
Figure Global Human Vaccine Sales Market Share by Product in 2018
Table Global Human Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Human Vaccine Revenue Share by Product (2014-2019)
Figure Global Human Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Human Vaccine Revenue Market Share by Product in 2018
Table Human Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global Human Vaccine Sales by End User (2014-2019) (M Doses)
Table Global Human Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Human Vaccine Market Share by End User (2014-2019)
Figure Global Sales Human Vaccine Market Share by End User in 2018
Figure North America Human Vaccine Sales Growth Rate 2014-2019 (M Doses)
Figure North America Human Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Human Vaccine Sales by Countries (2014-2019) (M Doses)
Table North America Human Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Human Vaccine Sales Market Share by Countries
Table North America Human Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Human Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Human Vaccine Revenue Market Share by Countries
Figure United States Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure United States Human Vaccine Revenue Growth Rate (2014-2019) (M Doses)
Figure Canada Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Canada Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Mexico Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Human Vaccine Sales by Product (2014-2019) (M Doses)
Table North America Human Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Human Vaccine Market Share by Product
Table North America Human Vaccine Sales by End User (2014-2019) (M Doses)
Table North America Human Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Human Vaccine Market Share by End User
Figure Europe Human Vaccine Sales Growth Rate 2014-2019 (M Doses)
Figure Europe Human Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Human Vaccine Sales by Countries (2014-2019) (M Doses)
Table Europe Human Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Human Vaccine Sales Market Share by Countries
Table Europe Human Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Human Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Human Vaccine Revenue Market Share by Countries
Figure Germany Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Germany Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure France Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure UK Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Italy Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Russia Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Human Vaccine Sales by Product (2014-2019) (M Doses)
Table Europe Human Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Human Vaccine Market Share by Product
Table Europe Human Vaccine Sales by End User (2014-2019) (M Doses)
Table Europe Human Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Human Vaccine Market Share by End User
Figure Asia Pacific Human Vaccine Sales Growth Rate 2014-2019 (M Doses)
Figure Asia Pacific Human Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Human Vaccine Sales by Countries (2014-2019) (M Doses)
Table Asia Pacific Human Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Human Vaccine Sales Market Share by Countries
Table Asia Pacific Human Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Human Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Human Vaccine Revenue Market Share by Countries
Figure China Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure China Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Japan Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Korea Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure India Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Australia Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Indonesia Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Malaysia Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Philippines Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Thailand Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Vietnam Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Singapore Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Human Vaccine Sales by Product (2014-2019) (M Doses)
Table Asia Pacific Human Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Human Vaccine Market Share by Product
Table Asia Pacific Human Vaccine Sales by End User (2014-2019) (M Doses)
Table Asia Pacific Human Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Human Vaccine Market Share by End User
Figure Central & South America Human Vaccine Sales Growth Rate 2014-2019 (M Doses)
Figure Central & South America Human Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Human Vaccine Sales by Countries (2014-2019) (M Doses)
Table Central & South America Human Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Human Vaccine Sales Market Share by Countries
Table Central & South America Human Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Human Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Human Vaccine Revenue Market Share by Countries
Figure Brazil Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Brazil Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Argentina Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Human Vaccine Sales by Product (2014-2019) (M Doses)
Table Central & South America Human Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Human Vaccine Market Share by Product
Table Central & South America Human Vaccine Sales by End User (2014-2019) (M Doses)
Table Central & South America Human Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Human Vaccine Market Share by End User
Figure Middle East and Africa Human Vaccine Sales Growth Rate 2014-2019 (M Doses)
Figure Middle East and Africa Human Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Human Vaccine Sales by Countries (2014-2019) (M Doses)
Table Middle East and Africa Human Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Human Vaccine Sales Market Share by Countries
Table Middle East and Africa Human Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Human Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Human Vaccine Revenue Market Share by Countries
Figure GCC Countries Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure GCC Countries Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Turkey Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure Egypt Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Human Vaccine Sales Growth Rate (2014-2019) (M Doses)
Figure South Africa Human Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Human Vaccine Sales by Product (2014-2019) (M Doses)
Table Middle East and Africa Human Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Human Vaccine Market Share by Product
Table Middle East and Africa Human Vaccine Sales by End User (2014-2019) (M Doses)
Table Middle East and Africa Human Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Human Vaccine Market Share by End User
Table CNBG Company Details
Table CNBG Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table CNBG Recent Development
Table Changsheng Life Company Details
Table Changsheng Life Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Changsheng Life Recent Development
Table Zhifei Company Details
Table Zhifei Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Zhifei Recent Development
Table ChengDa Bio Company Details
Table ChengDa Bio Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table ChengDa Bio Recent Development
Table Kangtai Company Details
Table Kangtai Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Kangtai Recent Development
Table SINOVAC BIOTECH Company Details
Table SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table SINOVAC BIOTECH Recent Development
Table Hissen Company Details
Table Hissen Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Hissen Recent Development
Table Walvax Biotechnology Company Details
Table Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Walvax Biotechnology Recent Development
Table GSK Company Details
Table GSK Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table GSK Recent Development
Table SANOFI Company Details
Table SANOFI Human Vaccine Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table SANOFI Recent Development
Table Rong An Company Details
Table NuoCheng Bio Company Details
Table Hualan Bio Company Details
Table Tiantan biological Company Details
Table Changchun Baike Company Details
Table Adimmune Company Details
Table Zhongyianke Biotech Company Details
Table Global Human Vaccine Sales Forecast by Regions 2019-2025 (M Doses)
Table Global Human Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Human Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Human Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Human Vaccine Sales Forecast by Product 2019-2025 (M Doses)
Table Global Human Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Human Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Human Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Human Vaccine Sales Forecast by End User 2019-2025 (M Doses)
Table Global Human Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Human Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure North America Human Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Human Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure Europe Human Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Human Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure Asia Pacific Human Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Human Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure Central & South America Human Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Human Vaccine Sales Growth Rate Forecast (2019-2025) (M Doses)
Figure Middle East and Africa Human Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Human Vaccine Value Chain
Table Human Vaccine Customers List
Table Human Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Povidone Iodine (PVP-I) Market Professional Survey 2019 by Manufacturers, Regions, Countries, Types and Applications, Forecast to 2024
    Published: 24-Apr-2019        Price: US 2900 Onwards        Pages: 144
    The Povidone Iodine (PVP-I) market was valued at XX Million US$ in 2018 and is projected to reach XX Million US$ by 2024, at a CAGR of XX% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2024 as the forecast period to estimate the market size for Povidone Iodine (PVP-I). Global Povidone Iodine (PVP-I) industry market professional research 2014-2024, is a report which provides the details about industry overview, industry chain, mark......
  • Global (United States, European Union and China) Diphtheria Vaccine Market Research Report 2019-2025
    Published: 24-Apr-2019        Price: US 3280 Onwards        Pages: 118
    In 2019, the market size of Diphtheria Vaccine is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Diphtheria Vaccine. This report studies the global market size of ......
  • Global (United States, European Union and China) Prazosin Hydrochloride (CAS 19237-84-4) Market Research Report 2019-2025
    Published: 24-Apr-2019        Price: US 3280 Onwards        Pages: 117
    In 2019, the market size of Prazosin Hydrochloride (CAS 19237-84-4) is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period. In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Prazosin Hydrochloride (CAS 19237-84-4). This......
  • Global Combination Therapy Drug Market Insights, Forecast to 2025
    Published: 24-Apr-2019        Price: US 3900 Onwards        Pages: 116
    The global Combination Therapy Drug market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Combination Therapy Drug market based on company, product type, end user and key regions. This report studies the global market size of Combination Therapy Drug in key regions like North America, Europe, Asia Pacific, Central & South America ......
  • Global Axitinib Market Insights, Forecast to 2025
    Published: 24-Apr-2019        Price: US 3900 Onwards        Pages: 114
    The global Axitinib market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Axitinib market based on company, product type, end user and key regions. This report studies the global market size of Axitinib in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consump......
  • Global Thalidomide Market Insights, Forecast to 2025
    Published: 24-Apr-2019        Price: US 3900 Onwards        Pages: 115
    The global Thalidomide market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Thalidomide market based on company, product type, end user and key regions. This report studies the global market size of Thalidomide in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on th......
  • Global Diphtheria Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Apr-2019        Price: US 3480 Onwards        Pages: 116
    Scope of the Report: The worldwide market for Diphtheria Vaccine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Diphtheria Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicati......
  • Global Diphtheria Vaccine Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
    Published: 23-Apr-2019        Price: US 3480 Onwards        Pages: 116
    Scope of the Report: The worldwide market for Diphtheria Vaccine is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Diphtheria Vaccine in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applicati......
  • Global Histone Deacetylase (HDAC) Inhibitors Market Insights, Forecast to 2025
    Published: 23-Apr-2019        Price: US 3900 Onwards        Pages: 117
    The global Histone Deacetylase (HDAC) Inhibitors market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Histone Deacetylase (HDAC) Inhibitors market based on company, product type, end user and key regions. This report studies the global market size of Histone Deacetylase (HDAC) Inhibitors in key regions like North America, Europe,......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs